Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 5c; cuts sales outlook

Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.65, $0.05 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.75 billion versus the consensus estimate of $1.75 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2023 EPS of $7.47-$7.57, versus the consensus of $7.50.

The company now expects FY revenue growth of 6-6.5%, down from the prior 6.5-7%.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
• Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance